Viatris Inc (VTRS): Depreciation & Amortization
$2.80B
Year ended 2025-12-31
$2.80B
Trailing 12 months to 2026-06-30
-2.6%
3-year compound annual growth
+4.8%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.80B | -3.3% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $2.89B | +5.6% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $2.74B | -9.5% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $3.03B | -32.8% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $4.51B | +103.4% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $2.22B | +9.7% | 2023-02-27, From 2020-01-01 |
| 2019-12-31 | $2.02B | -4.3% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $2.11B | n/a | 2021-03-01, From 2018-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Viatris Inc (VTRS) | 2025-12-31 | $2.80B | -3.3% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $543.70M | +12.6% |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $209.80M | +1.3% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $1.00B | -5.4% |
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $1.21B | -4.7% |
| Zoetis Inc. (ZTS) | 2025-12-31 | $487.00M | -2.0% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $141.69M | -17.5% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $680.00M | +2.7% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $41.60M | +26.8% |
Compare VTRS, REGN, VRTX, TEVA side by side · Screen every company in Pharmaceutical Preparations ↗